Browse > Article
http://dx.doi.org/10.7314/APJCP.2013.14.11.6249

Folate-Related Nutrients, Genetic Polymorphisms, and Colorectal Cancer Risk: the Fukuoka Colorectal Cancer Study  

Morita, Makiko (Department of Preventive Medicine, Graduate School of Medical Sciences, Kyushu University)
Yin, Guang (Department of Preventive Medicine, Graduate School of Medical Sciences, Kyushu University)
Yoshimitsu, Shin-Ichiro (Department of Preventive Medicine, Graduate School of Medical Sciences, Kyushu University)
Ohnaka, Keizo (Department of Geriatric Medicine, Graduate School of Medical Sciences, Kyushu University)
Toyomura, Kengo (Department of Preventive Medicine, Graduate School of Medical Sciences, Kyushu University)
Kono, Suminori (Department of Preventive Medicine, Graduate School of Medical Sciences, Kyushu University)
Ueki, Takashi (Department of Surgery and Oncology, Graduate School of Medical Sciences, Kyushu University)
Tanaka, Masao (Department of Surgery and Oncology, Graduate School of Medical Sciences, Kyushu University)
Kakeji, Yoshihiro (Department of Surgery and Science, Graduate School of Medical Sciences, Kyushu University)
Maehara, Yoshihiko (Department of Surgery and Science, Graduate School of Medical Sciences, Kyushu University)
Okamura, Takeshi (Department of Gastroenterological Surgery, National Kyushu Cancer Center)
Ikejiri, Koji (Division of Surgery, National Kyushu Medical Center)
Futami, Kitaroh (Department of Surgery, Fukuoka University Chikushi Hospital)
Maekawa, Takafumi (Department of Surgery, Fukuoka University Chikushi Hospital)
Yasunami, Yohichi (Department of Regenerative Medicine & Transplantation, Faculty of Medicine, Fukuoka University)
Takenaka, Kenji (Division of Surgery, Fukuoka City Hospital)
Ichimiya, Hitoshi (Hamanomachi General Hospital)
Terasaka, Reiji (Fukuoka Red Cross Hospital)
Publication Information
Asian Pacific Journal of Cancer Prevention / v.14, no.11, 2013 , pp. 6249-6256 More about this Journal
Abstract
One-carbon metabolism plays an important role in colorectal carcinogenesis. Meta-analyses have suggested protective associations of folate and vitamin $B_6$ intakes with colorectal cancer primarily based on studies in Caucasians, and genetic polymorphisms pertaining to the folate metabolism have been a matter of interest. Less investigated are the roles of methionine synthase (MTR) and thymidylate synthetase (TS) polymorphisms in colorectal carcinogenesis. In a study of 816 cases and 815 community controls in Japan, we investigated associations of dietary intakes of folate, methionine, vitamin $B_2$, vitamin $B_6$, and vitamin $B_{12}$ with colorectal cancer risk. The associations with MTR 2756A>G, MTRR 66A>G, and TSER repeat polymorphism were examined in 685 cases and 778 controls. Methionine and vitamin $B_{12}$ intakes were inversely associated with colorectal cancer risk, but the associations were totally confounded by dietary calcium and n-3 fatty acids. The other nutrients showed no association with the risk even without adjustment for calcium and n-3 fatty acids. The TSER 2R allele was dose-dependently associated with an increased risk. The MTR and MTRR polymorphisms were unrelated to colorectal cancer risk. There was no measurable gene-gene or gene-nutrient interaction, but increased risk associated with the TSER 2R allele seemed to be confined to individuals with high folate status. This study does not support protective associations for folate and vitamin $B_6$. The TSER 2R allele may confer an increased risk of colorectal cancer. The role of the TSER polymorphism in colorectal carcinogenesis may differ by ethnicity.
Keywords
Colorectal cancer; methionine synthase; thymidylate synthase; B-vitamins; case-control study;
Citations & Related Records
Times Cited By KSCI : 1  (Citation Analysis)
연도 인용수 순위
1 Eussen SJ, Vollset SE, Igland J, et al (2010). Plasma folate, related genetic variants, and colorectal cancer risk in EPIC. Cancer Epidemiol Biomarkers Prev, 19, 1328-40.   DOI   ScienceOn
2 Eussen SJ, Vollset SE, Hustad S, et al (2010). Plasma vitamins B2, B6, and B12, and related genetic variants as predictors of colorectal cancer risk. Cancer Epidemiol Biomarkers Prev, 19, 2549-61.   DOI   ScienceOn
3 Giovannucci E, Rimm EB, Ascherio A, et al (1995). Alcohol, low-methionine-low-folate diets, and risk of colon cancer in men. J Natl Cancer Inst, 87, 265-73.   DOI   ScienceOn
4 Harnack L, Jacobs DR Jr, Nicodemus K, et al (2002). Relationship of folate, vitamin B6, vitamin B12, and methionine intake to incidence of colorectal cancers. Nutr Cancer, 43, 152-8.   DOI   ScienceOn
5 Huang Y, Han S, Li Y, Mao Y, Xie Y (2007). Different roles of MTHFR C677T and A1298C polymorphisms in colorectal adenoma and colorectal cancer: a meta-analysis. J Hum Genet, 52, 73-85.
6 Hubner RA, Houlston RS (2007). MTHFR C677T and colorectal cancer risk: A meta-analysis of 25 populations. Int J Cancer, 120, 1027-35.
7 Hubner RA, Houlston RS (2009). Folate and colorectal cancer prevention. Br J Cancer, 100, 233-9.   DOI   ScienceOn
8 Ishihara J, Otani T, Inoue M, et al (2007). Low intake of vitamin B-6 is associated with increased risk of colorectal cancer in Japanese men. J Nutr, 137, 1808-14.   DOI
9 Isomura K, Kono S, Moore MA, et al (2006). Physical activity and colorectal cancer: the Fukuoka colorectal cancer study. Cancer Sci, 97, 1099-104.   DOI   ScienceOn
10 Kennedy DA, Stern SJ, Moretti M, et al (2011). Folate intake and the risk of colorectal cancer: a systematic review and meta-analysis. Cancer Epidemiol, 35, 2-10.   DOI   ScienceOn
11 Kim DH, Smith-Warner SA, Spiegelman D, et al (2010). Pooled analyses of 13 prospective cohort studies on folate intake and colon cancer. Cancer Causes Control, 21, 1919-30.   DOI
12 Kim J, Cho YA, Kim DH, et al (2012). Dietary intake of folate and alcohol, MTHFR C677T polymorphism, and colorectal cancer risk in Korea. Am J Clin Nutr, 95, 405-12.   DOI   ScienceOn
13 Kim YI (2008). Folic acid supplementation and cancer risk: point. Cancer Epidemiol Biomarkers Prev, 17, 2220-5.   DOI   ScienceOn
14 Kimura Y, Kono S, Toyomura K, et al (2007). Meat, fish and fat intake in relation to subsite-specific risk of colorectal cancer: the Fukuoka colorectal cancer study. Cancer Sci, 98, 590-7.   DOI   ScienceOn
15 Kono S, Toyomura K, Yin G, Nagano J, Mizoue T (2004). A case-control study of colorectal cancer in relation to lifestyle factors and genetic polymorphisms: design and conduct of the Fukuoka colorectal cancer study. Asian Pac J Cancer Prev, 5, 393-400.
16 Kono S, Chen K (2005). Genetic polymorphisms of methylenetetrahydrofolate reductase and colorectal cancer and adenoma. Cancer Sci, 96, 535-42.   DOI   ScienceOn
17 Larsson SC, Orsini N, Wolk A (2010). Vitamin B6 and risk of colorectal cancer: a meta-analysis of prospective studies. JAMA, 303, 1077-83.   DOI   ScienceOn
18 Le Marchand L, Donlon T, Hankin JH, et al (2002). B-vitamin intake, metabolic genes, and colorectal cancer risk (United States). Cancer Causes Control, 13, 239-48.   DOI   ScienceOn
19 Yang Z, Zhang XF, Liu HX, Hao YS, Zhao CL (2012). MTHFR C677T polymorphism and colorectal cancer risk in Asians, a meta-analysis of 21 studies. Asian Pac J Cancer Prev, 13, 1203-8.   DOI   ScienceOn
20 Winder T, Lenz HJ (2010). Molecular predictive and prognostic markers in colon cancer. Cancer Treat Rev, 36, 550-6.   DOI   ScienceOn
21 Yin G, Kono S, Toyomura K, et al (2004). Methylenetetrahydrofolate reductase C677T and A1298C polymorphisms and colorectal cancer: the Fukuoka colorectal cancer study. Cancer Sci, 95, 908-13.   DOI   ScienceOn
22 Zhang X, Lee JE, Ma J, et al (2012). Prospective cohort studies of vitamin $B_{6}$ intake and colorectal cancer incidence: modification by time? Am J Clin Nutr, 96, 874-81.   DOI
23 Zschabitz S, Cheng TY, Neuhouser ML,et al (2013). B vitamin intakes and incidence of colorectal cancer: results from the women’s health initiative observational study cohort. Am J Clin Nutr, 97, 332-43.   DOI
24 Ma J, Stampfer MJ, Christensen B, et al (1999). A polymorphism of the methionine synthase gene: association with plasma folate, vitamin B12, homocyst(e)ine, and colorectal cancer risk. Cancer Epidemiol Biomarkers Prev, 8, 825-9.
25 Le Marchand L, Wilkens LR, Kolonel LN, Henderson BE (2005). The MTHFR C677T polymorphism and colorectal cancer: the multiethnic cohort study. Cancer Epidemiol Biomarkers Prev, 14, 1198-203.   DOI   ScienceOn
26 Le Marchand L, White KK, Nomura AM, et al (2009). Plasma levels of B vitamins and colorectal cancer risk: the multiethnic cohort study. Cancer Epidemiol Biomarkers Prev, 18, 2195-201.   DOI   ScienceOn
27 Ma J, Stampfer MJ, Giovannucci E, et al (1997). Methylenetetrahydrofolate reductase polymorphism, dietary interactions, and risk of colorectal cancer. Cancer Res, 57, 1098-102.
28 Mason JB, Choi SW (2005). Effects of alcohol on folate metabolism: implications for carcinogenesis. Alcohol, 35, 235-41.   DOI   ScienceOn
29 Matsuo K, Ito H, Wakai K, et al (2005). One-carbon metabolism related gene polymorphisms interact with alcohol drinking to influence the risk of colorectal cancer in Japan. Carcinogenesis, 26, 2164-71.   DOI   ScienceOn
30 Mizoue T, Kimura Y, Toyomura K, et al (2008). Calcium, dairy foods, vitamin D, and colorectal cancer risk: the Fukuoka Colorectal Cancer Study. Cancer Epidemiol Biomarkers Prev, 17, 2800-7.   DOI   ScienceOn
31 Murtaugh MA, Curtin K, Sweeney C, et al (2007). Dietary intake of folate and co-factors in folate metabolism, MTHFR polymorphisms, and reduced rectal cancer. Cancer Causes Control, 18, 153-63.   DOI   ScienceOn
32 Sharp L, Little J, Brockton NT, et al (2008). Polymorphisms in the methylenetetrahydrofolate reductase (MTHFR) gene, intakes of folate and related B vitamins and colorectal cancer: a case-control study in a population with relatively low folate intake. Br J Nutr, 99, 379-89.
33 Razzak AA, Oxentenko AS, Vierkant RA, et al (2012). Associations between intake of folate and related micronutrients with molecularly defined colorectal cancer risks in the Iowa women’s health study. Nutr Cancer, 64, 899-910.   DOI   ScienceOn
34 Sanjoaquin MA, Allen N, Couto E, Roddam AW, Key TJ (2005). Folate intake and colorectal cancer risk: a meta-analytical approach. Int J Cancer, 113, 825-8.   DOI   ScienceOn
35 Sharp L, Little J (2004). Polymorphisms in genes involved in folate metabolism and colorectal neoplasia: a HuGE review. Am J Epidemiol, 159, 423-43.   DOI   ScienceOn
36 Shrubsole MJ, Yang G, Gao YT, et al (2009). Dietary B vitamin and methionine intakes and plasma folate are not associated with colorectal cancer risk in Chinese women. Cancer Epidemiol Biomarkers Prev, 18, 1003-6.   DOI   ScienceOn
37 Stevens VL, McCullough ML, Sun J, et al (2011). High levels of folate from supplements and fortification are not associated with increased risk of colorectal cancer. Gastroenterology, 141, 98-105   DOI   ScienceOn
38 Theodoratou E, Farrington SM, Tenesa A, et al (2008). Dietary vitamin B6 intake and the risk of colorectal cancer. Cancer Epidemiol Biomarkers Prev, 17, 171-82.   DOI   ScienceOn
39 Trinh BN, Ong CN, Coetzee GA, Yu MC, Laird PW (2002). Thymidylate synthase: a novel genetic determinant of plasma homocysteine and folate levels. Hum Genet, 111, 299-302.   DOI   ScienceOn
40 Chen J, Giovannucci E, Kelsey K, et al (1996). A methylenetetrahydrofolate reductase polymorphism and the risk of colorectal cancer. Cancer Res, 56, 4862-4.
41 Chen J, Hunter DJ, Stampfer MJ, et al (2003). Polymorphism in the thymidylate synthase promoter enhancer region modifies the risk and survival of colorectal cancer. Cancer Epidemiol Biomarkers Prev, 12, 958-62.
42 De Vogel S, Wouters KA, Gottschalk RW, et al (2009). Genetic variants of methyl metabolizing enzymes and epigenetic regulators: associations with promoter CpG island hypermethylation in colorectal cancer. Cancer Epidemiol Biomarkers Prev, 18, 3086-96.   DOI   ScienceOn
43 Ding W, Zhou DL, Jiang X, Lu LS (2013). Methionine synthase A2756G polymorphism and risk of colorectal adenoma and cancer: evidence based on 27 studies. PLoS One, 9, 60508.
44 Ulrich CM, Curtin K, Potter JD, et al (2005). Polymorphisms in the reduced folate carrier, thymidylate synthase, or methionine synthase and risk of colon cancer. Cancer Epidemiol Biomarkers Prev, 14, 2509-16.   DOI   ScienceOn
45 Uchida K, Kimura Y, Shirota T, Kono S (2007). Validity and reproducibility of the PC-assisted dietary interview used in the Fukuoka colorectal cancer study. Asian Pac J Cancer Prev, 8, 583-90.
46 Ulrich CM, Bigler J, Bostick R, Fosdick L, Potter JD (2002). Thymidylate synthase promoter polymorphism, interaction with folate intake, and risk of colorectal adenomas. Cancer Res, 62, 3361-4.
47 Ulrich CM (2005). Nutrigenetics in cancer research: folate metabolism and colorectal cancer. J Nutr, 135, 2698-702.   DOI
48 Ulvik A, Vollset SE, Hansen S, et al (2004). Colorectal cancer and the methylenetetrahydrofolate reductase 677C -> T and methionine synthase 2756A -> G polymorphisms: a study of 2,168 case-control pairs from the JANUS cohort. Cancer Epidemiol Biomarkers Prev, 13, 2175-80.
49 Van Guelpen B, Hultdin J, Johansson I, et al (2006). Low folate levels may protect against colorectal cancer. Gut, 55, 1461-6.   DOI   ScienceOn
50 Weinstein SJ, Albanes D, Selhub J, et al (2008). One-carbon metabolism biomarkers and risk of colon and rectal cancers. Cancer Epidemiol Biomarkers Prev, 17, 3233-40.   DOI   ScienceOn
51 Willett W, Stampfer MJ (1986). Total energy intake: implications for epidemiologic analyses. Am J Epidemiol, 124, 17-27.   DOI
52 Williams EA (2012). Folate, colorectal cancer and the involvement of DNA methylation. Proc Nutr Soc, 71, 592-7.   DOI   ScienceOn